Martingale Asset Management L P Has $2.61 Million Position in ICU Medical, Inc. (NASDAQ:ICUI)

Martingale Asset Management L P lifted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1,100.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 16,800 shares of the medical instruments supplier's stock after buying an additional 15,400 shares during the quarter. Martingale Asset Management L P owned 0.07% of ICU Medical worth $2,607,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd purchased a new position in ICU Medical in the fourth quarter valued at about $33,000. Murphy & Mullick Capital Management Corp acquired a new position in ICU Medical during the 4th quarter worth $52,000. Venturi Wealth Management LLC increased its position in shares of ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after purchasing an additional 206 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after buying an additional 300 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its position in shares of ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after acquiring an additional 567 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Remove Ads

ICU Medical Trading Down 0.8 %

NASDAQ ICUI traded down $1.09 on Tuesday, hitting $139.45. 111,777 shares of the stock were exchanged, compared to its average volume of 263,416. The company's 50-day moving average price is $147.87 and its two-hundred day moving average price is $160.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 52-week low of $93.36 and a 52-week high of $196.26. The company has a market capitalization of $3.42 billion, a price-to-earnings ratio of -30.51 and a beta of 0.86.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on ICUI shares. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday, April 4th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Finally, Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, ICU Medical currently has an average rating of "Buy" and a consensus price target of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.